| . |
| |
Home
Academics
Graduate Program
M.S.
Ph.D.
Faculty
Ali, Nawab
Baltosser, William H
Bayrak, Coskun
Beger, Richard
Benes, Helen
Berleant, Dan
Bowyer, John F
Bruhn, Russel
Bush, John
Chan, Yupo
Chiang, Chia-Chu
Compadre, Cesar
Dagtas, Serhan
Mock, Donald
Nagarajan, Radhakris
Patterson, Tucker
Pidugu, Srikanth B
Pierce, Elizabeth M
Preissl, Hubert T
Ramaswamy, Srinivasa
Reis, Robert J S
Seker, Remzi
Simpson, Pippa
Slikker, William
Soulsby, Sr., Michae
Suva, Larry
Tang, Peiyi
Thompson, Gary A
Tong, Weida
Tudoreanu, M Eduard
Vanbiervliet, Alan G
Wigand, Rolf T
Xu, Xiaowei
Zhang, Jianjun
Zhou, Yi-Hong
Darsey, Jerry A
Elsalloukh, Hassan
Epstein, Joshua
Eswaran, Hari
Fuscoe, James C
Gealt, Michael A
Govindan, Rathinaswa
Gray, Wayne L
He, Qingfang
Iqbal, Kamran
Jennings, Steven F
Jo, Chan-Hee
Kane, Cynthia (Cindy
Kaufmann, Eric R
Kieber-Emmons, Thoma
Light, Kim
Liu, Xian
Lowery, Curtis L
Luba, James
Ma, Xiaodong
Milanova, Mariofanna
Ounpraseuth, Songthi
FAQ
Graduate Forms
Undergraduate minor
Courses
Certificates
Admission
Research
Events
Resources
Contacts
Jobs
Calendar
|
|
. |
|
Dr. Tucker Patterson
|
|
Adjunct Assistant Professor of Pharmacology & Toxicology
|
| Affiliation |
UAMS Medicine |
| Office |
53D-203N |
| Email |
tucker.patterson AT fda.hhs.gov |
| Phone |
870-543-7427 |
| Fax |
870-543-7745 |
| Mail |
Division of Neurotoxicology, HFT-132 NCTR/FDA 3900 NCTR Rd.
Jefferson, Arkansas 72079 |
| Core Areas |
|
|
| Research Areas |
Dr. Patterson's primary research interests include neurotoxicology and neuropharmacology, including development and validation of animal models to predict neurotoxicity in humans, using both pharmacodynamic and pharmacokinetic approaches; developing novel assays to measure neurotoxic compounds and their metabolites in the blood and brain, and determining their effects on neurotransmitters; and implementing and validating genomic and proteomic techniques utilizing laser capture microdissection (LCM) to search for biomarkers of neurotoxicity. Over the past three years he has been incorporating molecular biology techniques (real-time PCR, RNA amplification, microarray, etc.) into the already established approaches (neurochemistry, neurohistology, behavior) within the Division of Neurotoxicology.
|
|
|
|